Venture Capital Archives - Page 73 of 103

knownwell Expands in Greater Boston, Opens Second Clinic in Woburn

August 19, 2025

Philips to Invest Over $150 Million in U.S. Manufacturing and R&D Expansion

August 15, 2025

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

THIS WEEK'S STORIES

GoodRx Partners with Novo Nordisk to Offer Ozempic and Wegovy for $499 Per Month

August 18, 2025

Sarepta Therapeutics Advances siRNA Program for DM1, Sells Arrowhead Stake to Fund $100M Milestone Payment

August 14, 2025

IntegriChain Names Shai Fiss Chief AI and Technology Officer, Brad Burget to Become CTO Emeritus

August 18, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

PharmaCyte Biotech Raises $7 Million in Private Placement Led by Existing Investors

Vyome Launches Strategic Review of Livechain Stake

SetPoint Medical Secures $140 Million to Advance Rheumatoid Arthritis Therapy, Expands Leadership Team

Apreo Health Raises $130 Million in Series B to Advance Trial and Commercialization of Novel Emphysema Device

Strand Therapeutics Secures $153 Million in Series B to Accelerate Programmable mRNA Therapy Pipeline

Most Read

Sequencing.com Partners with PGxAI to Expand Pharmacogenomics Access and Reduce Drug Reactions

Aldeyra Therapeutics Secures FDA Fast Track Status for Retinitis Pigmentosa Therapy

Kelonia Therapeutics Begins First-in-Human Trial of In Vivo CAR-T Therapy for Multiple Myeloma

eGenesis Adds Industry Veterans Douglas Williams and Adam Craig to Board of Directors

EDITOR PICKS